Expression analysis of cytoskeleton regulator RNA and Cyclin Dependent Kinase Inhibitor 2B genes in breast cancer

Abstract

BACKGROUND:

Breast cancer has been found to be associated with deregulation of several non-coding genes and mRNA coding genes.

OBJECTIVE:

To assess expressions of CYTOR and CDKN2B in breast cancer and adjacent samples and find their relevance with clinical data.

METHODS:

We enumerated expression level of CDKN2B and CYTOR in 43 newly diagnosed breast cancer samples and their adjacent specimens using real-time PCR method Expression data was judged using Wilcoxon matched-pairs signed rank test.

RESULTS:

CYTOR level was higher in tumors compared with adjacent tissues. Nevertheless, there was no difference in expression of CDKN2B between these two sets of tissues. ROC curve analysis showed that CYTOR levels can differentiate between tumoral and adjacent tissues with AUC, specificity and sensitivity values of 0.65, 37% and 92% ( $P=$ 0.017). There was a positive correlation between expression levels of CYTOR and CDKN2B genes in breast cancer tissues ( $r=$ 0.5 and $P=$ 0.0008) as well as adjacent tissues ( $r=$ 0.79 and $P<$ 0.0001). Relative expression level of CDKN2B in normal tissues was associated with clinical stage ( $P=$ 0.014). Moreover, relative expression level of CDKN2B in tumor tissues was associated with the body weight. There was no other association between expressions of CYTOR and CDKN2B and clinical or pathological variables.

CONCLUSIONS:

Cumulatively, this study offers evidence for involvement of these genes in the pathoetiology of breast cancer.

Keywords

Breast cancer CYTOR CDKN2B

Get full access to this article

View all access options for this article.

References

Sung

, et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin 71(3) (2021), 209–249.

, et al., CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A, Oncogene 37(1) (2018), 128–138.

Jafri

, et al., Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma, Cancer Discov 5(7) (2015), 723–9.

, et al., Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA, Nature 451(7175) (2008), 202–6.

Khorshidi

H.R.

, et al., ANril genetic variants in iranian breast cancer patients, Cell Journal 19 (2017), 72–78.

Gil

and Peters

, Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all, Nature Reviews Molecular Cell Biology 7(9) (2006), 667–677.

Ghafouri-Fard

, et al., The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells, Frontiers in Oncology 10 (2020).

Wang

, et al., The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68, Molecular Cancer 17(1) (2018), 1–16.

Zhao

, et al., Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer, Cell Cycle 14(19) (2015), 3112–3123.

10.

, et al., HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma, Cellular Physiology and Biochemistry 37(2) (2015), 687–696.

11.

Moradi

M.-T.

Hatami

and Rahimi

, Circulating CYTOR as a Potential Biomarker in Breast Cancer, International Journal of Molecular and Cellular Medicine 9(1) (2020), 83–90.

12.

Liu

, et al., lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR-125a-5p, International Journal of Molecular Medicine 45(2) (2020), 497–509.

13.

, et al., LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis, Cell Cycle 17(8) (2018), 974–984.

14.

Ghafouri-Fard

, et al., An update on the role of long non-coding RNAs in the pathogenesis of breast cancer, Pathology Research and Practice 219 (2021).

15.

Swarbrick

Fernandez-Martinez

and Perou

C.M.

, Gene-Expression Profiling to Decipher Breast Cancer Inter- and Intratumor Heterogeneity, Cold Spring Harb Perspect Med (2023).

16.

Yue

, et al., Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer, Molecular Therapy 24(12) (2016), 2064–2077.

17.

Yue

, et al., A positive feed-forward loop between LncRNA-CYTOR and Wnt/β-catenin signaling promotes metastasis of colon cancer, Molecular Therapy 26(5) (2018), 1287–1298.

18.

, et al., The Long Noncoding RNA Cytoskeleton Regulator RNA (CYTOR)/miRNA-24-3p Axis Facilitates Nasopharyngeal Carcinoma Progression by Modulating GAD1 Expression, Journal of Oncology 2023 (2023).